Evommune, Inc. (EVMN)

25.71 -0.29 (-1.12%) USD  |  NYSE  |  Mar 02, 16:00
26.07 +0.36 (+1.40%) After-Hours: 20:00
More

Evommune EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for EVMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Moderna, Inc. Upgrade
BillionToOne, Inc. --
Nektar Therapeutics Upgrade
CorMedix, Inc. Upgrade